Eli Lilly's rheumatoid arthritis drug accelerates recovery in COVID-19 patients – Reuters UK

Eli Lilly’s rheumatoid arthritis drug accelerates recovery in COVID-19 patients – Reuters UK

Eli Lilly and Co said on Monday its rheumatoid arthritis drug shortened the recovery time for hospitalized COVID-19 patients also given Gilead Sciences Inc’s antiviral remdesivir.

Read More…

You May Also Like